Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Neuhaus

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
The Lancet. Neurology|May 26, 2004
Are statins a treatment option for multiple sclerosis?Oliver Neuhaus, Olaf Stüve, Scott S Zamvil, et al.
CNS Drugs|September 28, 2005
Evaluation of HMG-CoA reductase inhibitors for multiple sclerosis: opportunities and obstaclesOliver Neuhaus, Olaf Stüve, Scott S Zamvil, et al.
Brain : a Journal of Neurology|October 23, 2002
Glatiramer acetate-specific T-helper 1- and 2-type cell lines produce BDNF: implications for multiple sclerosis therapy. Brain-derived neurotrophic factorTjalf Ziemssen, Tania Kümpfel, Wolfgang E F Klinkert, et al.
Plos One|December 19, 2017
Downregulation of monocytic differentiation via modulation of CD147 by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitorsManda V Sasidhar, Sai Krishnaveni Chevooru, Oliver Eickelberg, et al.
Der Nervenarzt|May 25, 2004
[Cannabinoids in multiple sclerosis. Opportunity or hazard?]Oliver Neuhaus, Bernd C Kieseier, Ansgar Klimke, et al.
Journal of the Neurological Sciences|May 5, 2005
Secretion of brain-derived neurotrophic factor by glatiramer acetate-reactive T-helper cell lines: Implications for multiple sclerosis therapyTjalf Ziemssen, Tania Kümpfel, Hauke Schneider, et al.
Experimental Neurology|June 29, 2007
Limited effects of glatiramer acetate in the high-copy number hSOD1-G93A mouse model of ALSHans-Jörg Habisch, Birgit Schwalenstöcker, Ruth Danzeisen, et al.
Fortschritte Der Neurologie-Psychiatrie|March 21, 2019
[It is more than transportation time only: "Drip and ship" delays endovascular thrombectomy in stroke]Oliver Neuhaus, Rainer Schimana, Dietmar Bengel, et al.
CNS Drugs|April 12, 2011
Glatiramer acetate in the treatment of multiple sclerosis: emerging concepts regarding its mechanism of actionPatrice H Lalive, Oliver Neuhaus, Mahdia Benkhoucha, et al.
Journal of Neuroimmunology|September 21, 2005
Multiple sclerosis: Mitoxantrone promotes differential effects on immunocompetent cells in vitroOliver Neuhaus, Heinz Wiendl, Bernd C Kieseier, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
The Lancet. Neurology|May 26, 2004
Are statins a treatment option for multiple sclerosis?Oliver Neuhaus, Olaf Stüve, Scott S Zamvil, et al.
CNS Drugs|September 28, 2005
Evaluation of HMG-CoA reductase inhibitors for multiple sclerosis: opportunities and obstaclesOliver Neuhaus, Olaf Stüve, Scott S Zamvil, et al.
Brain : a Journal of Neurology|October 23, 2002
Glatiramer acetate-specific T-helper 1- and 2-type cell lines produce BDNF: implications for multiple sclerosis therapy. Brain-derived neurotrophic factorTjalf Ziemssen, Tania Kümpfel, Wolfgang E F Klinkert, et al.
Plos One|December 19, 2017
Downregulation of monocytic differentiation via modulation of CD147 by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitorsManda V Sasidhar, Sai Krishnaveni Chevooru, Oliver Eickelberg, et al.
Der Nervenarzt|May 25, 2004
[Cannabinoids in multiple sclerosis. Opportunity or hazard?]Oliver Neuhaus, Bernd C Kieseier, Ansgar Klimke, et al.
Journal of the Neurological Sciences|May 5, 2005
Secretion of brain-derived neurotrophic factor by glatiramer acetate-reactive T-helper cell lines: Implications for multiple sclerosis therapyTjalf Ziemssen, Tania Kümpfel, Hauke Schneider, et al.
Experimental Neurology|June 29, 2007
Limited effects of glatiramer acetate in the high-copy number hSOD1-G93A mouse model of ALSHans-Jörg Habisch, Birgit Schwalenstöcker, Ruth Danzeisen, et al.
Fortschritte Der Neurologie-Psychiatrie|March 21, 2019
[It is more than transportation time only: "Drip and ship" delays endovascular thrombectomy in stroke]Oliver Neuhaus, Rainer Schimana, Dietmar Bengel, et al.
CNS Drugs|April 12, 2011
Glatiramer acetate in the treatment of multiple sclerosis: emerging concepts regarding its mechanism of actionPatrice H Lalive, Oliver Neuhaus, Mahdia Benkhoucha, et al.
Journal of Neuroimmunology|September 21, 2005
Multiple sclerosis: Mitoxantrone promotes differential effects on immunocompetent cells in vitroOliver Neuhaus, Heinz Wiendl, Bernd C Kieseier, et al.
Pageof 4